Viewing Study NCT00030706


Ignite Creation Date: 2025-12-26 @ 1:16 PM
Ignite Modification Date: 2025-12-30 @ 7:57 AM
Study NCT ID: NCT00030706
Status: COMPLETED
Last Update Posted: 2018-09-28
First Post: 2002-02-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
Sponsor: Montefiore Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module